A PROSPECTIVE PHASE II STUDY OF INDUCTION ERLOTINIB THERAPY IN STAGE IIIA-N2 NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Zhong, W. -Z.
Yang, X. -N.
Liao, R. -Q.
Nie, Q.
Su, J.
Zhang, X. -C.
An, S. -J.
Zhou, Q.
Yang, J. -J.
Wu, Y. -L.
机构：
[1] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] A prospective phase II study of induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong, Wenzhao
    Yang, Xuening
    Liao, Riqiang
    Nie, Qiang
    Su, Jian
    Chen, Zhihong
    Zhang, Xuchao
    An, Shejuan
    Zhou, Qing
    Yang, Jinji
    Wu, Yi Long
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong Wen-Zhao
    Yang Xue-Ning
    Guo Ai-Lin
    Chen Hua-Jun
    Su Jian
    Liao Ri-Qiang
    Zhou Qing
    Nie Qiang
    Xu Chong-Rui
    Yang Jin-Ji
    Wu Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S590 - S591
  • [3] Is surgery indicated for stage IIIA-N2 non-small-cell lung cancer?
    Gounant, V.
    Lavole, A.
    Epaud, C.
    Rosencher, L.
    Milleron, B.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2007, 63 (03) : 135 - 137
  • [4] Induction erlotinib or gemcitabine/carboplatin factorial assignment therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong, W.
    Yang, X.
    Liao, R.
    Nie, Q.
    Dong, S.
    Su, J.
    Zhang, X.
    Zhou, Q.
    Yang, J.
    Wu, Y. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Induction eriotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong, W.
    Yang, X.
    Liao, R.
    Nie, Q.
    Zhang, X.
    Su, J.
    Zhou, Q.
    Xu, C.
    Yang, J.
    Wu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Generalized or personalized treatment for stage IIIA-N2 non-small-cell lung cancer?
    Vansteenkiste, Johan
    Van Damme, Valerie
    Dooms, Christophe
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1605 - 1609
  • [7] Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer
    Kappers, Ingrid
    Klomp, Houke M.
    Burgers, Jacobus A.
    Van Zandwijk, Nico
    Haas, Rick L. M.
    van Pel, Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) : 4205 - 4207
  • [8] Resection of Persistent Stage IIIA-N2 Non-small Cell Lung Cancer After Induction Therapy
    Andrews, Weston G.
    Louie, Brian E.
    Bograd, Adam J.
    ANNALS OF THORACIC SURGERY, 2022, 114 (06): : 2392 - 2393
  • [9] Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations
    Wen, Miaomiao
    Wang, Lei
    Wang, Xuejiao
    Yang, Sanhu
    Sun, Ying
    Xia, Jinghua
    Zhang, Yanning
    Zhang, Zhipei
    Huang, Lijun
    Jiang, Tao
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12) : 686 - 693
  • [10] Scalpels, beams, drugs, and dreams: Challenges of stage IIIA-N2 non-small-cell lung cancer
    Johnson, David H.
    Rusch, Valerie W.
    Turrisi, Andrew T.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (06) : 415 - 418
12345